Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.82
1.93
NAV
₹503.06
₹417.30
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8306.35 Cr
₹4076.67 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
1 Year
8.41%
5.80%
3 Year
23.74%
25.08%
5 Year
15.18%
16.50%
Equity
99.68%
98.53%
Cash
0.32%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.08% |
Lupin Ltd. | 7.99% |
Divi's Laboratories Ltd. | 6.56% |
Dr. Reddy's Laboratories Ltd. | 5.81% |
Cipla Ltd. | 5.67% |
Apollo Hospitals Enterprise Ltd. | 5.17% |
Medplus Health Services Ltd. | 3.70% |
Vijaya Diagnostic Centre Ltd. | 3.49% |
Max Healthcare Institute Ltd. | 3.49% |
Ajanta Pharma Ltd. | 3.41% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999
